Albumin binding improves nanobody pharmacokinetics for dual-modality PET/NIRF imaging of CEACAM5 in colorectal cancer models

Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2591-2594. doi: 10.1007/s00259-023-06266-5.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Albumins
  • Carcinoembryonic Antigen
  • Cell Line, Tumor
  • Colorectal Neoplasms* / diagnostic imaging
  • GPI-Linked Proteins
  • Humans
  • Positron-Emission Tomography* / methods

Substances

  • Albumins
  • CEACAM5 protein, human
  • Carcinoembryonic Antigen
  • GPI-Linked Proteins